BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29080987)

  • 41. No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer.
    Behrendt FF; Lensing C; Keil S; Mottaghy FM; Verburg FA
    J Med Imaging Radiat Oncol; 2016 Aug; 60(4):498-505. PubMed ID: 27297449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. JOURNAL CLUB: CT dose optimization for whole-body PET/CT examinations.
    Tonkopi E; Ross AA; MacDonald A
    AJR Am J Roentgenol; 2013 Aug; 201(2):257-63. PubMed ID: 23883207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultralow-dose chest computed tomography for pulmonary nodule detection: first performance evaluation of single energy scanning with spectral shaping.
    Gordic S; Morsbach F; Schmidt B; Allmendinger T; Flohr T; Husarik D; Baumueller S; Raupach R; Stolzmann P; Leschka S; Frauenfelder T; Alkadhi H
    Invest Radiol; 2014 Jul; 49(7):465-73. PubMed ID: 24598443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of PET/CT instead of CT-only when planning for radiation therapy does not notably increase life years lost in children being treated for cancer.
    Kornerup JS; Brodin P; Birk Christensen C; Björk-Eriksson T; Kiil-Berthelsen A; Borgwardt L; Munck Af Rosenschöld P
    Pediatr Radiol; 2015 Apr; 45(4):570-81. PubMed ID: 25378209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management.
    Chalaye J; Luciani A; Enache C; Beaussart P; Lhermite C; Evangelista E; Sasanelli M; Safar V; Meignan M; Haioun C; Rahmouni A; Itti E
    Leuk Lymphoma; 2014 Dec; 55(12):2887-92. PubMed ID: 24597987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocol.
    Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mondal A; Mishra AK; Dwarakanath BS
    Indian J Med Res; 2015 Dec; 142(6):721-31. PubMed ID: 26831421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI.
    Grueneisen J; Sawicki LM; Schaarschmidt BM; Suntharalingam S; von der Ropp S; Wetter A; Ruhlmann V; Quick HH; Forsting M; Umutlu L
    PLoS One; 2016; 11(6):e0157880. PubMed ID: 27327617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the risk of radiation exposure from new 18FDG PET/CT plans versus conventional X-ray plans in patients with pediatric cancers.
    Murano T; Tateishi U; Iinuma T; Shimada N; Daisaki H; Terauchi T; Moriyama N; Inoue T
    Ann Nucl Med; 2010 May; 24(4):261-7. PubMed ID: 20237874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
    Antoch G; Saoudi N; Kuehl H; Dahmen G; Mueller SP; Beyer T; Bockisch A; Debatin JF; Freudenberg LS
    J Clin Oncol; 2004 Nov; 22(21):4357-68. PubMed ID: 15514377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach.
    Muehe AM; Theruvath AJ; Lai L; Aghighi M; Quon A; Holdsworth SJ; Wang J; Luna-Fineman S; Marina N; Advani R; Rosenberg J; Daldrup-Link HE
    Mol Imaging Biol; 2018 Apr; 20(2):324-335. PubMed ID: 28721605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of effective radiation doses from X-ray, CT, and PET/CT in pediatric patients with neuroblastoma using a dose monitoring program.
    Kim YY; Shin HJ; Kim MJ; Lee MJ
    Diagn Interv Radiol; 2016; 22(4):390-4. PubMed ID: 27306659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma.
    Roe RH; Finger PT; Kurli M; Tena LB; Iacob CE
    Ophthalmology; 2006 Oct; 113(10):1854-8. PubMed ID: 16860867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Very low-dose coronary artery calcium scanning with high-pitch spiral acquisition mode: comparison between 120-kV and 100-kV tube voltage protocols.
    Marwan M; Mettin C; Pflederer T; Seltmann M; Schuhbäck A; Muschiol G; Ropers D; Daniel WG; Achenbach S
    J Cardiovasc Comput Tomogr; 2013; 7(1):32-8. PubMed ID: 23333186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
    Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
    Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
    Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
    Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Whole-body CT for lymphoma staging: feasibility of halving radiation dose and risk by iterative image reconstruction.
    Meyer M; Klein SA; Brix G; Fink C; Pilz L; Jafarov H; Hofmann WK; Schoenberg SO; Henzler T
    Eur J Radiol; 2014 Feb; 83(2):315-21. PubMed ID: 24355659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The optimal use of PET/CT in the management of lymphoma patients.
    Milgrom SA; Rechner L; Berthelsen A
    Br J Radiol; 2021 Nov; 94(1127):20210470. PubMed ID: 34415777
    [No Abstract]   [Full Text] [Related]  

  • 60. Low-dose CT examinations in Crohn's disease: Impact on image quality, diagnostic performance, and radiation dose.
    Kambadakone AR; Prakash P; Hahn PF; Sahani DV
    AJR Am J Roentgenol; 2010 Jul; 195(1):78-88. PubMed ID: 20566800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.